Product Description
Bortezomib Injection
Bortenat 2mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Purpose and IndicationBortecad (Bortezomib Injection) is primarily used as a first or subsequent treatment for adults with multiple myeloma or mantle cell lymphoma. As an antineoplastic agent, it works by interfering with the growth of cancer cells, helping to slow disease progression. This makes it a valuable option for patients in need of targeted cancer therapy.
Usage Instructions and AdministrationThis medication is administered intravenously or subcutaneously by a healthcare professional. Each vial is reconstituted with sterile water before injection. Dosage adjustments and schedules are determined by the prescribing doctor based on patient response and overall health. Proper handling and administration play a crucial role in maximizing effectiveness and minimizing risk.
Packaging and Quality AssurancePackaged in a durable glass vial with a protective flip-off seal, Bortecad ensures secure storage of the medication's lyophilized powder form. Manufactured in WHO-GMP and ISO-certified facilities in India, its pharmaceutical grade quality and strict adherence to international standards guarantee safety and efficacy for every batch distributed.
FAQ's of Bortezomib Injection:
Q: How should Bortecad (Bortezomib Injection) be prepared and administered?
A: Bortecad must be reconstituted with sterile water for injection by a healthcare professional before use. Once properly diluted, it is administered either intravenously or subcutaneously in a clinical setting.
Q: What conditions is Bortecad commonly used to treat?
A: Bortecad is mainly prescribed for the management of multiple myeloma and mantle cell lymphoma, two types of cancers affecting the blood and lymphatic system.
Q: When should Bortecad injection be given to patients?
A: The injection is given according to a dosing schedule determined by the prescribing doctor, tailored to the patient's specific type of cancer, treatment cycle, and individual response to therapy.
Q: Where should Bortecad be stored before use?
A: Store Bortecad below 30C and protect it from light to maintain its potency and stability until use. It should be kept in its original glass vial until reconstitution.
Q: What are the main benefits of using Bortecad for eligible patients?
A: Bortecad is a targeted therapy that helps slow the growth of cancerous cells, offering an effective option for patients with multiple myeloma or mantle cell lymphoma. Its pharmaceutical grade assures consistent efficacy and safety.
Q: Is a prescription required to obtain Bortecad (Bortezomib Injection)?
A: Yes, Bortecad is a prescription medication and should only be used under the supervision of a qualified healthcare provider.
Q: What are the inactive ingredients in Bortecad and why are they important?
A: In addition to Bortezomib, Bortecad contains mannitol as an inactive ingredient, which helps stabilize the lyophilized powder for proper reconstitution and consistent dosing.